<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04037800</url>
  </required_header>
  <id_info>
    <org_study_id>CH-URO2019001</org_study_id>
    <nct_id>NCT04037800</nct_id>
  </id_info>
  <brief_title>A RCT to Compare Early Continence Recovery After RARP With or Without Sustainable Functional Urethral Reconstruction</brief_title>
  <official_title>The Impact of Sustainable Functional Urethral Reconstruction(SFUR) for Robotic-assisted Laparoscopic Radical Prostatectomy(RARP) on Short-term Continence Recovery: a Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Changhai Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Changhai Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study is a prospective randomized controlled trail to compare early urinary continence
      recovery after robotic-assisted radical prostatectomy with or without sustainable functional
      urethral reconstruction (SFUR).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Early urinary incontinence has always been a tricky problem for both patients and urologists,
      even though over 90% patients can recover 12 months after operation. Many urologists are
      trying to improve the surgery, but these new technics mainly help locally advanced prostate
      cancer by better preserving Neurovascular Bundles, urethra, external sphincter or other
      periurethral supporting structures. Sustainable functional urethral reconstruction (SFUR) is
      a novel technic which can improve early urinary incontinence for both locally and locally
      advanced prostate cancer, and even for those with high volume prostate by providing adequate
      urethral length with bladder neck tubularization and sustainable periurethral support with
      peritoneal flap. The purpose of this study is to compare early continence recovery, oncologic
      outcomes and postoperative complications after RARP with or without this new technic.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 8, 2019</start_date>
  <completion_date type="Anticipated">April 8, 2021</completion_date>
  <primary_completion_date type="Anticipated">October 8, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Early urinary continence recovery</measure>
    <time_frame>1 month after the removal of the urinary catheter</time_frame>
    <description>Number of pads and 24-hour pad weights（Patients with 0 pad/one security liner per day(24-hour pad weights≤50g ) shall be regarded continence）</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Early urinary continence recovery</measure>
    <time_frame>one day, 2 weeks and 1 month after catheter removal</time_frame>
    <description>Two definitions shall be used: Number of pads(Patients with 0 pad/one security liner per day(24-hour pad weights≤50g ) shall be regarded continence) and early urinary recovery quantification in Grams (PAD-test 24h)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Urinary continence recovery</measure>
    <time_frame>within 3/6/12 months from the intervention</time_frame>
    <description>Two definitions shall be used: 0 pad/one security liner per day（24-hour pad weights≤50g）, and 0 pad per day</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Peri and postoperative complications</measure>
    <time_frame>6-month/1-year median follow up</time_frame>
    <description>Clavien-Dindo complications</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Post-operative oncological outcomes, as defined by post-operative Prostate-Specific antigen (PSA) value</measure>
    <time_frame>1-year median follow up</time_frame>
    <description>Patients who reach a post-operative PSA value &lt;0.2 ng/ml will be reported</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evaluation of urinary incontinence</measure>
    <time_frame>before surgery, 1 month after catheter removal, 3/6/12 months after surgery</time_frame>
    <description>International Consultation on Incontinence Questionnaire-Urinary Incontinence-Short Form (ICIQ-UI-SF)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Post-operative urinary function and urinary function-related quality of life</measure>
    <time_frame>before surgery, 3/6/12 months after surgery</time_frame>
    <description>International Prostatic Symptom Score(IPSS)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Post-operative sexual function, as measured by Sexual Health Inventory for Men (SHIM)</measure>
    <time_frame>6-month/1-year median follow up</time_frame>
    <description>Two definitions of potency shall be used: SHIM &gt;=17 and erections sufficient for penetrative intercourse</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">96</enrollment>
  <condition>Prostate Cancer</condition>
  <condition>Urinary Incontinence</condition>
  <arm_group>
    <arm_group_label>SFUR-RARP</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients in which RARP with sustainable functional urethral reconstruction (SFUR) is performed.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard RARP</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients in which standard RARP is performed.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>SFUR-RARP</intervention_name>
    <description>Robotic-assisted radical prostatectomy with sustainable functional urethral reconstruction (SFUR)</description>
    <arm_group_label>SFUR-RARP</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Standard RARP</intervention_name>
    <description>Robotic-assisted radical prostatectomy without sustainable functional urethral reconstruction (SFUR)</description>
    <arm_group_label>Standard RARP</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  ≥40, but ≤75 years old；

          -  Histological confirmed prostate cancer；

          -  Localized or locally advanced prostate cancer；

          -  Presence of urinary continence prior to the procedure;

          -  Informed consent signed;

        Exclusion Criteria:

          -  Metastatic prostate cancer confirmed by ECT, PSMA or whole-body MRI;

          -  Presence of any prostatic surgery(such as transurethral resection, laser therapy,
             microwave therapy, radiofrequency ablation and so on) prior to the procedure;

          -  Radiation therapy of the prostate or pelvis prior to the procedure;

          -  Uncontrolled intercurrent illness that would limit compliance with study requirements;

          -  Any condition that contraindicates a radical prostatectomy;
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yinghao Sun, MD, PHD</last_name>
    <role>Study Chair</role>
    <affiliation>Changhai Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Xu Gao, MD, PHD</last_name>
    <phone>86-021-31161718</phone>
    <email>gaoxu.changhai@foxmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Zepeng Jia</last_name>
    <email>zepengjia@163.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Changhai Hospital</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>200082</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xu Gao, MD, PHD</last_name>
      <phone>86-021-31161718</phone>
      <email>gaoxu.changhai@foxmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Zepeng Jia</last_name>
      <phone>+8616628766616</phone>
      <email>zepengjia@163.com</email>
    </contact_backup>
    <investigator>
      <last_name>Xu Sun, MD, PHD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Xu Gao, MD, PHD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <reference>
    <citation>Ficarra V, Novara G, Rosen RC, Artibani W, Carroll PR, Costello A, Menon M, Montorsi F, Patel VR, Stolzenburg JU, Van der Poel H, Wilson TG, Zattoni F, Mottrie A. Systematic review and meta-analysis of studies reporting urinary continence recovery after robot-assisted radical prostatectomy. Eur Urol. 2012 Sep;62(3):405-17. doi: 10.1016/j.eururo.2012.05.045. Epub 2012 Jun 1. Review.</citation>
    <PMID>22749852</PMID>
  </reference>
  <reference>
    <citation>Dev HS, Sooriakumaran P, Srivastava A, Tewari AK. Optimizing radical prostatectomy for the early recovery of urinary continence. Nat Rev Urol. 2012 Jan 24;9(4):189-95. doi: 10.1038/nrurol.2012.2. Review.</citation>
    <PMID>22270136</PMID>
  </reference>
  <reference>
    <citation>Bessede T, Sooriakumaran P, Takenaka A, Tewari A. Neural supply of the male urethral sphincter: comprehensive anatomical review and implications for continence recovery after radical prostatectomy. World J Urol. 2017 Apr;35(4):549-565. doi: 10.1007/s00345-016-1901-8. Epub 2016 Aug 2. Review.</citation>
    <PMID>27484205</PMID>
  </reference>
  <reference>
    <citation>Pavlovich CP, Rocco B, Druskin SC, Davis JW. Urinary continence recovery after radical prostatectomy - anatomical/reconstructive and nerve-sparing techniques to improve outcomes. BJU Int. 2017 Aug;120(2):185-196. doi: 10.1111/bju.13852. Epub 2017 Apr 17. Review.</citation>
    <PMID>28319318</PMID>
  </reference>
  <reference>
    <citation>Bianchi L, Turri FM, Larcher A, De Groote R, De Bruyne P, De Coninck V, Goossens M, D'Hondt F, De Naeyer G, Schatteman P, Mottrie A. A Novel Approach for Apical Dissection During Robot-assisted Radical Prostatectomy: The &quot;Collar&quot; Technique. Eur Urol Focus. 2018 Sep;4(5):677-685. doi: 10.1016/j.euf.2018.01.004. Epub 2018 May 7.</citation>
    <PMID>29402756</PMID>
  </reference>
  <verification_date>December 2019</verification_date>
  <study_first_submitted>July 24, 2019</study_first_submitted>
  <study_first_submitted_qc>July 27, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">July 30, 2019</study_first_posted>
  <last_update_submitted>December 18, 2019</last_update_submitted>
  <last_update_submitted_qc>December 18, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">December 20, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Changhai Hospital</investigator_affiliation>
    <investigator_full_name>Yinghao Sun</investigator_full_name>
    <investigator_title>Chief Physician</investigator_title>
  </responsible_party>
  <keyword>Prostate cancer</keyword>
  <keyword>Prostatectomy</keyword>
  <keyword>Robotic surgery</keyword>
  <keyword>Urinary incontinence</keyword>
  <keyword>Sustainable functional urethral reconstruction</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Prostatic Neoplasms</mesh_term>
    <mesh_term>Urinary Incontinence</mesh_term>
    <mesh_term>Enuresis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

